| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Genetics, DBS, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [K. F., K. K., S. J.], and Institut für Klinische Molekularbiologie and Tumorgenetik, GSF, Munich, Germany [K. F., G-W. B.]
Using the phage
LIZ-based transgenic in vivo mutagenesis assay, mean mutant rates were determined in the spleen of mice exposed to sustained oxidative stress and were found to be increased approximately 3-fold in plasmacytoma-susceptible BALB/c and C.D2-Idh1-Pep3 mice, but not in plasmacytoma-resistant DBA/2N mice. This finding suggests a correlation between the genetic susceptibility to inflammation-induced peritoneal plasmacytomagenesis and the phenotype of increased mutagenesis in lymphoid tissues, raising the possibility that plasmacytoma resistance genes may inhibit tumor development by minimizing oxidative mutagenesis in B cells.
1 Supported in part by a grant from the Mildred-Scheel-Stiftung for cancer research (to G-W. B.).
2 To whom requests for reprints should be addressed, at Laboratory of Genetics, National Cancer Institute, NIH, Building 37, Room 2B03, Bethesda, MD 20892-4255. Phone: (301) 496-2101; Fax: (301) 402-1031; E-mail: felixk@dc37a.nci.nih.gov.
Received 1/22/98. Accepted 3/ 3/98.
This article has been cited by other articles:
![]() |
K. Felix, K. A. Kelliher, G.-W. Bornkamm, and S. Janz Elevated Mutant Frequencies in Lymphoid Tissues Persist throughout Plasmacytoma Development in BALB/c.{{lambda}}LIZ Mice Cancer Res., August 1, 1999; 59(15): 3621 - 3626. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |